Success Stories
Dispute Resolved

Veeva and IQVIA Establish Historic Life Sciences Partnership

Dispute Resolved

Veeva and IQVIA Establish Historic Life Sciences Partnership

Randal HeebMatt Hoelle
Key Contacts
Randal Heeb and Matt Hoelle

Veeva and IQVIA Establish Historic Life Sciences Partnership

What happens when two life sciences rivals battle over critical healthcare data?

Veeva Systems Inc. (“Veeva”) and IQVIA, Inc. (“IQVIA”) both provide data, software and solutions to help life sciences companies market and sell life-saving medicines. In 2018, IQVIA sued Veeva for trade secret misappropriation. Veeva countersued for antitrust monopolization claims.

The dispute carried significant implications not only for the parties involved, but also for the broader life sciences industry, as pharmaceutical companies increasingly depend on integrated data and software solutions. The outcome of the dispute had the potential to reshape how customers could access and use critical healthcare data across competing platforms.

FTI Consulting competition expert Dr. Randal Heeb was retained by Veeva to provide expert testimony on the antitrust claims, specifically regarding market definition and harm to competition.

Our Impact

3D digital illustration of a transparent capsule containing a DNA strand, resting on a blue circuit board.
3D digital illustration of a transparent capsule containing a DNA strand, resting on a blue circuit board.

Slide for 3D digital illustration of a transparent capsule containing a DNA strand, resting on a blue circuit board.

Dr. Heeb provided economic analysis regarding the impact of market conduct and its implications for competition.

3D digital illustration of multiple blue and pink DNA double helix strands against a dark background.

Slide for 3D digital illustration of multiple blue and pink DNA double helix strands against a dark background.

In August 2025, after eight years of legal dispute, the companies settled all claims and agreed to third-party data and access agreements that allow customers to use IQVIA data in Veeva software, and vice versa — a transformative outcome that will improve clinical and commercial efficiency for customers.

Our Role

Brining clarity to complex healthcare technology markets

Dr. Heeb and his team of economists reviewed tens of thousands of documents and datasets that detailed the two companies’ businesses in two data markets and five software markets.

  1. Dr. Heeb submitted three expert reports and provided testimony at the deposition, and his analysis on antitrust liability provided the economic foundation in support of Veeva’s antitrust claims.

  2. The analysis provided statistical evidence that precisely defined the boundaries of the data and software markets in which Veeva and IQVIA compete and the markets in which IQVIA’s alleged anticompetitive conduct occurred.

  3. Dr. Heeb also offered analysis on the trade secret misappropriation claims.

Related Experts

Discover Your Team

Real-world experience that delivers.

See why FTI Consulting is the leading global expert firm for organizations facing crisis and transformation.

Discover Our Expertise
Several images of experts
More Success Stories

Deep Expertise in Action

See how our expert-driven, industry-focused approach
produces real results in an increasingly complex world.

All Success Stories
Value Protected

Defending Reputation and Keeping OpenAI’s Nearly $1 Trillion IPO on Track

In March 2019, OpenAI Inc. — a nonprofit organization founded in 2015 by Elon Musk, Sam Altman and Greg Brockman, now known as The OpenAI Foundation — publicly announced the formation of a for-profit affiliate, now known as OpenAI Group PBC, that would enable OpenAI to raise many billions of dollars in capital investment. In August 2024, Mr. Musk, who had resigned from the nonprofit’s board of directors in February 2018, brought a lawsuit alleging, among other things, that the OpenAI defendants, with the assistance of Microsoft, had broken promises to use his charitable contributions to maintain OpenAI as a nonprofit organization and prioritized profits over the founding mission. At trial, Mr. Musk asserted claims for breach of charitable trust, aiding and abetting breach of charitable trust, and restitution based on unjust enrichment. Among other remedies, Mr. Musk sought to unwind OpenAI’s 2025 recapitalization and disgorgement of OpenAI’s and Microsoft’s alleged wrongful gains.Compass Lexecon and Professors Ilya A. Strebulaev, Daniel Hemel and Somesh Jha were retained by the OpenAI defendants through their outside counsel, Wachtell, Lipton, Rosen & Katz, to act as consultants and expert witnesses in the litigation.

Illustration for Defending Reputation and Keeping OpenAI’s Nearly $1 Trillion IPO on Track
Funds Recovered

Finding $15.3 Billion Lost in Madoff’s Ponzi Scheme

In December 2008, Bernie Madoff admitted that the investment advisory business within his firm was a Ponzi scheme, setting off his arrest and a chain reaction of events throughout the financial services world and philanthropic communities. A Trustee under the Securities Investor Protection Act was appointed to liquidate Madoff’s firm and to recover the proceeds from his Ponzi scheme. FTI Consulting experts were engaged by Irving Picard, the Trustee, and BakerHostetler, the Trustee’s counsel.

Illustration for Finding $15.3 Billion Lost in Madoff’s Ponzi Scheme
Current Opportunities

Discover a career at
the center of the action.

Explore Opportunities